Edition:
United Kingdom

Integra LifeSciences Holdings Corp (IART.OQ)

IART.OQ on NASDAQ Stock Exchange Global Select Market

57.25USD
3:44pm BST
Change (% chg)

$2.58 (+4.72%)
Prev Close
$54.67
Open
$56.30
Day's High
$58.92
Day's Low
$55.11
Volume
107,157
Avg. Vol
196,179
52-wk High
$58.92
52-wk Low
$42.25

Chart for

About

Integra LifeSciences Holdings Corporation is a medical technology company. The Company focuses on the development, manufacturing, and marketing of surgical implants and medical instruments. Its segments include Specialty Surgical Solutions, which offers specialty surgical instrumentation for a range of specialties, including... (more)

Overall

Beta: 0.68
Market Cap(Mil.): $4,399.72
Shares Outstanding(Mil.): 78.96
Dividend: --
Yield (%): --

Financials

  IART.OQ Industry Sector
P/E (TTM): 40.16 35.20 32.31
EPS (TTM): 1.36 -- --
ROI: 4.76 14.20 12.97
ROE: 12.00 16.94 14.84

BRIEF-Integra Lifesciences Reports Q1 Adjusted Earnings Per Share $0.58

* INTEGRA LIFESCIENCES REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

11:28am BST

BRIEF-Integra LifeSciences Says CEO's 2017 Compensation Was $7.1 Mln

* INTEGRA LIFESCIENCES HOLDINGS CORP SAYS CEO PETER J. ARDUINI'S 2017 TOTAL COMPENSATION WAS $7.1 MILLION VERSUS $7 MILLION IN 2016 – SEC FILING ‍​ Source: (https://bit.ly/2HdNFnd) Further company coverage:

06 Apr 2018

BRIEF-Integra Lifesciences Holdings Reports Q4 EPS Of $0.56

* INTEGRA LIFESCIENCES REPORTS FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS

27 Feb 2018

BRIEF-Integra Lifesciences Q4 Adjusted Earnings Per Share $0.64

* INTEGRA LIFESCIENCES REPORTS FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS

27 Feb 2018

BRIEF-Integra Lifesciences Announces Preliminary Q4 Earnings Per Share View $0.55, Revenue View $351.0

* - ‍ORGANIC REVENUE GROWTH IN Q4 IS EXPECTED TO BE ABOUT 5.5%, ABOVE COMPANY'S IMPLIED GUIDANCE OF ABOUT 4%​

08 Jan 2018

BRIEF-Integra Lifesciences Holdings Corp ‍Reaffirms 2017 Financial Guidance As Provided On Oct 26, 2017​

* - ‍REAFFIRMING 2017 FINANCIAL GUIDANCE AS PROVIDED ON OCTOBER 26, 2017​

11 Dec 2017

BRIEF-Capital Research Global Investors Reports 11.1 Pct Passive Stake In Integra Lifesciences As Of Nov 30

* CAPITAL RESEARCH GLOBAL INVESTORS REPORTS 11.1 PERCENT PASSIVE STAKE IN INTEGRA LIFESCIENCES HOLDINGS CORP AS OF NOVEMBER 30 - SEC FILING Source text: (http://bit.ly/2jb88l1) Further company coverage:

08 Dec 2017

BRIEF-Integra Lifesciences Q3 adjusted earnings per share $0.45

* Integra Lifesciences reports third quarter 2017 financial results

26 Oct 2017

Earnings vs. Estimates